首页> 外国专利> Triazinyllactames, process for their preparation, their use as stabilisators for synthetic organic polymers and polymers stabilised by them

Triazinyllactames, process for their preparation, their use as stabilisators for synthetic organic polymers and polymers stabilised by them

机译:三嗪基内酰胺类,其制备方法,其作为合成有机聚合物和由其稳定化的聚合物的稳定剂的用途

摘要

1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, NL, SE A compound of the formula (I) see diagramm : EP0075849,P13,F1 in which m is 0 or 1, n is also 0 or 1 and A is C4 to C11 alkylene, R**1 , when m is 0, has the meaning of hydrogen, of C1 to C18 alkyl, of C3 to C21 alkoxyalkyl, of C5 to C12 cycloalkyl, which can be substituted by C1 to C4 alkyl, or phenyl or naphthyl, which can be substituted by up to two Cl or C1 to C4 alkyl radicals or by one C1 to C4 alkoxy or C1 to C2 carboalkoxy group, of C7 to C14 phenylalkyl or of a group of the formula (II) see diagramm : EP0075849,P13,F2 wherein R**3 is hydrogen or methyl and R**4 is hydrogen, C1 to C4 alkyl, or is 2,3-epoxypropyl, allyl or benzyl, R**1 and R**2 , when m is 1, are identical or different and represent hydrogen, C1 to C18 alkyl, C5 to C12 cycloalkyl, which can be substituted by up to four C1 to C4 alkyl groups, phenyl, which can be substituted by up to two C1 to C4 alkyl radicals, C7 to C14 phenylalkyl or a group of the formula (II), X1 and X2 , when n is 0, are identical or different and represent halogen, phenyl or a group of the formulae (III), (IV) or (V) see diagramm : EP0075849,P13,F3 see diagramm : EP0075849,P13,F4 -DR**9 (V) but when n is 1, X2 is always a group of the formula see diagramm : EP0075849,P14,F1 with A being C4 to C11 alkylene, wherein, in the formulae (III), (IV) and (V), R**5 and R**6 are identical or different and represent radicals listed for R**2 and R**6 additionally has the meaning of C3 to C21 alkoxyalkyl, or R**5 and R**6 together with the N atom connecting them, also represent a pyrrolidine ring or a piperidine, morpholine or hexamethyleneimine ring which is unsubstituted or substituted by up to four C1 to C4 alkyl groups, r, s and t are identical or different whole numbers from 2 to 6 and v is from 0 to 3, R**7 and R**8 represent identical of different radicals with the meanings indicated for R**2 , T has the meaning of a group of the formula (VI) see diagramm : EP0075849,P14,F2 with X3 and X4 being identical or different radicals of the formulae (III), (IV) or (V), R**9 is one of the radicals mentioned under R**1 , when m is 0, and Y represents C2 to C18 alkylene, C2 to C12 bis(propyloxy)alkylene, monocycloalkylene, dicycloalkylene or tricycloalkylene having 6 to 18 C atoms, which can be substituted by up to four methyl groups and in which up to two C atoms can be replaced by N atoms which can carry propylene groups, or Y represents C6 to C18 arylene, or C7 to C14 aralkylene, or a piperazinylene radical can also take the place of the group see diagramm : EP0075849,P14,F3 or C5 to C6 azamonocycloalkylene or azadicycloalkylene radicals, substituted by up to four methyl groups, can take the place of the group see diagramm : EP0075849,P14,F4 or see diagramm : EP0075849,P14,F5 and in formula (I), at least one group of the formula (II) is present, preferably at least one group of the formula (II) per triazine ring. 1. Claims for the Contracting State : AT A process for the preparation of triazinyllactames of the formula (I) see diagramm : EP0075849,P15,F2 in which m is 0 or 1, n is also 0 or 1 and A is C4 to C11 alkylene, R**1 , when m is 0, has the meaning of hydrogen, of C1 to C18 alkyl, of C3 to C21 alkoxyalkyl, of C5 to C12 cycloalkyl, which can be substituted by C1 to C4 alkyl, or phenyl or naphthyl, which can be substituted by up to two Cl or C1 to C4 alkyl radicals or by one C1 to C4 alkoxy or C1 to C2 carboalkoxy group, of C7 to C14 phenylalkyl or of a group of the formula (II) see diagramm : EP0075849,P16,F1 wherein R**3 is hydrogen or methyl and R**4 is hydrogen, C1 to C4 alkyl, or is 2,3-epoxypropyl, allyl or benzyl, R**1 and R**2 , when m is 1, are identical or different and represent hydrogen, C1 to C18 alkyl, C5 to C12 cycloalkyl, which can be substituted by up to four C1 to C4 alkyl groups phenyl, which can be substituted by up to two C1 to C4 alkyl radicals C7 to C14 phenylalkyl or a group of the formula (II), X1 and X2 , when n is 0, are identical or different and represent halogen, phenyl or a group of the formulae (III), (IV) or (V) see diagramm : EP0075849,P16,F2 see diagramm : EP0075849,P16,F3 -DR**9 (V) but when n is 1, X2 is always a group of the formula see diagramm : EP0075849,P16,F4 with A being C4 to C11 alkylene, wherein, in the formulae (III), (IV) and (V), R**5 and R**6 are identical or different and represent radicals listed for R**2 and R**6 additionally has the meaning of C3 to C21 alkoxyalkyl, or R**5 and R**6 , together with the N atom connecting them, also represent a pyrrolidine ring or a piperidine, morpholine or hexamethyleneimine ring which is unsubstituted or substituted by up to four C1 to C4 alkyl groups, r, s, and t are identical or different whole numbers from 2 to 6 and v is from 0 to 3, R**7 and R**8 represent identical of different radicals with the meanings indicated for R**2 , T has the meaning of a group of the formula (VI) see diagramm : EP0075849,P16,F5 with X3 and X4 being identical or different radicals of the formulae (III), (IV) or (V), R**9 is one of the radicals mentioned under R**1 , when m is 0, and Y represents C2 to C18 alkylene, C2 to C12 bis(propyloxy)alkylene, monocycloalkylene, dicycloalkylene or tricycloalkylene having 6 to 18 C atoms, which can be substituted by up to four methyl groups and in which up to two C atoms can be replaced by N atoms which can carry propylene groups, or Y represents C6 to C18 arylene, or C7 to C14 aralkylene, or a piperazinylene radical can also take the place of the group see diagramm : EP0075849,P17,F1 or C5 to C9 azamonocycloalkylene or azadicycloalkylene radicals, substituted by up to four methyl groups, can take the place of the group see diagramm : EP0075849,P17,F2 or see diagramm : EP0075849,P17,F3 and in formula (I), at least one group of the formula (II) is present, preferably at least one group of the formula (II) per triazine ring, which comprises reacting a compound of the formula (VII) see diagramm : EP0075849,P17,F4 in which R**1 , R**2 , X1 , X2 , Y, m and n have the meanings indicated above and Hal is preferably chlorine, in an inert organic solvent at 100 to 200 degrees C with 1.0 to 1.05 times the equivalent amount, relative to the halogen atoms envisaged for the reaction, of the alkali metal salt of a lactam having 4 to 11 methylene groups.
机译:1.对缔约国的索赔:BE,CH,DE,FR,GB,IT,LI,NL,SE式(I)的化合物参见示意图:EP0075849,P13,F1,其中m为0或1,n也是0或1并且A是C4至C11亚烷基,R ** 1,当m为0时,具有氢的含义,C1至C18烷基,C3至C21烷氧基烷基,C5至C12环烷基,可以是被C1至C4烷基或苯基或萘基取代,其可以被C7至C14苯烷基或一个基团的至多两个Cl或C1至C4烷基或一个C1至C4烷氧基或C1至C2碳烷氧基取代式(II)的化合物,参见图:EP0075849,P13,F2,其中R ** 3为氢或甲基,R ** 4为氢,C1至C4烷基,或为2,3-环氧丙基,烯丙基或苄基,R * * 1和R ** 2,当m为1时,相同或不同,表示氢,C1至C18烷基,C5至C12环烷基,最多可被四个C1至C4烷基取代,苯基为最多被两个C1至C4烷基,C7至C14苯基烷基或一个当n为0时,式(II)的基团X 1和X 2相同或不同,并且代表卤素,苯基或式(III),(IV)或(V)的基团,参见图:EP0075849,P13, F 3参见示意图:EP0075849,P13,F4-DR ** 9(V),但当n为1时,X2始终是该式的基团。参见示意图:EP0075849,P14,F1,A为C4至C11亚烷基,其中,式(III),(IV)和(V),R ** 5和R ** 6相同或不同,并且代表针对R ** 2和R ** 6列出的基团,另外具有C3至C21烷氧基烷基的含义,或R ** 5和R ** 6与连接它们的N原子一起,也代表吡咯烷环或哌啶,吗啉或六亚甲基亚胺环,它们未被取代或被至多四个C1至C4烷基,r,s取代和t是2到6相同或不同的整数,v是0到3,R ** 7和R ** 8表示相同的不同基团,其含义与R ** 2相同,T的含义为a式(VI)的基团示意图:EP0075849,P14,F2,其中X3和X4是式(III),(IV)或(V)的相同或不同基团,当m为m时,R ** 9为R ** 1中提及的基团之一是0,且Y表示C 2至C 18亚烷基,C 2至C 12双(丙氧基)亚烷基,具有6至18个C原子的单环亚烷基,二环亚烷基或三环亚烷基,其可以被最多四个甲基取代并且其中最多两个C原子可以被可带有丙烯基的N原子取代,或Y表示C6至C18亚芳基,或C7至C14亚芳基,或哌嗪子基团也可以代替该基团,见图:EP0075849,P14,F3或C5至C6最多可被四个甲基取代的氮杂单环亚烷基或氮杂二环亚烷基可以取代该基团,参见图:EP0075849,P14,F4或参见图:EP0075849,P14,F5,并且在式(I)中,至少一个存在式(II),优选每个三嗪环具有至少一个式(II)基团。 1.对缔约国的索赔:AT制备式(I)的三叠氮基内酰胺的方法,参见示意图:EP0075849,P15,F2,其中m为0或1,n也为0或1,A为C4至C11当m为0时,亚烷基R ** 1的含义为氢,C 1至C 18烷基,C 3至C 21烷氧基烷基,C 5至C 12环烷基,其可以被C 1至C 4烷基,或苯基或萘基取代可以被C7至C14苯基烷基或式(II)基团的至多两个Cl或C1至C4烷基或一个C1至C4烷氧基或C1至C2碳烷氧基取代,参见示意图:EP0075849, P16,F1,其中R ** 3为氢或甲基,R ** 4为氢,C1至C4烷基,或为2,3-环氧丙基,烯丙基或苄基,R ** 1和R ** 2,当m为图1中相同或不同的氢代表氢,C 1 -C 18烷基,C 5 -C 12环烷基,其可被多达四个C 1 -C 4烷基苯基取代,其可被多达两个C 1 -C 4烷基C 7 -C 10取代。 C14苯基烷当n为0时,基团或式(II)的基团X 1和X 2相同或不同,并且表示卤素,苯基或式(III),(IV)或(V)的基团,参见图:EP0075849 ,P16,F2参见示意图:EP0075849,P16,F3-DR ** 9(V),但当n为1时,X2始终是该式的基团,参见示意图:EP0075849,P16,F4,A为C4至C11亚烷基,其中,在式(III),(IV)和(V)中,R ** 5和R ** 6相同或不同,并且代表针对R ** 2列出的基团,并且R ** 6还具有C3的含义。与C 21烷氧基烷基或R ** 5和R ** 6相连的N原子也代表未被取代或被至多四个C1至C4烷基取代的吡咯烷环或哌啶,吗啉或六亚甲基亚胺环,r,s和t为2到6相同或不同的整数,v为0到3,R ** 7和R ** 8表示不同基团的相同,其含义与R ** 2相同,T具有式(VI)的基团的含义,参见示意图:EP0075849,P16,F5,其中X3和X4是式(III),(IV)或(V)的相同或不同基团,R ** 9是在R ** 1下提及的基团之一,当m为0时,且Y表示C 2至C 18亚烷基,C 2至C 12具有6至18个碳原子的双(丙氧基)亚烷基,单环亚烷基,二环亚烷基或三环亚烷基,其可以被取代最多四个甲基,其中最多两个C原子可以被可以带有丙烯基的N原子取代,或者Y代表C6至C18亚芳基,或C7至C14亚芳基,或者哌嗪基也可以取代该基团参见示意图:EP0075849,P17,F1或C5至C9的氮杂单环亚烷基或氮杂二环亚烷基,最多被四个甲基取代,可以代替该基团参见示意图:EP0075849,P17,F2或参见示意图:EP0075849,P17, F3和在式(I)中,存在至少一个式(II)基团,优选至少一个基团包括使式(VII)的化合物反应的每个三嗪环的式(II)的化合物的结构,参见图:EP0075849,P17,F4,其中R ** 1,R ** 2,X1,X2,Y,m和n具有上述含义,并且Hal优选为氯,在惰性有机溶剂中于100至200摄氏度下,相对于为该反应设想的卤素原子而言,当量为1.0至1.05倍当量内酰胺的碱金属盐。 4至11个亚甲基。

著录项

  • 公开/公告号EP0075849B1

    专利类型

  • 公开/公告日1987-07-22

    原文格式PDF

  • 申请/专利权人 HOECHST AKTIENGESELLSCHAFT;

    申请/专利号EP19820108750

  • 发明设计人 WIEZER HARTMUT DR.;PFAHLER GERHARD DR.;

    申请日1982-09-22

  • 分类号C07D401/12;C08K5/34;

  • 国家 EP

  • 入库时间 2022-08-22 07:15:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号